AN AUTOPSY STUDY OF SYSTEMIC FUNGAL-INFECTIONS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

被引:26
作者
JANDRLIC, M
KALENIC, S
LABAR, B
NEMET, D
JAKICRAZUMOVIC, J
MRSIC, M
PLECKO, V
BOGDANIC, V
机构
[1] ZAGREB UNIV HOSP,DEPT MICROBIOL,ZAGREB 10000,CROATIA
[2] ZAGREB UNIV HOSP,DEPT MED,DIV HEMATOL,ZAGREB 10000,CROATIA
[3] ZAGREB UNIV HOSP,DEPT PATHOL,ZAGREB 10000,CROATIA
关键词
D O I
10.1007/BF01690991
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to determine the incidence of fungal infections detected on autopsy in a group of 40 patients with hematologic malignancies treated with intensive chemotherapy or bone marrow transplantation, and to evaluate the risk factors for fungal infections. A control group included 38 patients with nonhematologic diseases and without granulocytopenia but with at least one of the known risk factors for fungal infections. Standard histopathological and microbiological methods were used. A higher incidence of invasive fungal infections was found in patients with hematologic malignancies as compared to the control group (p < 0.01). The predominant causes of fungal infections were Candida albicans and Aspergillus spp. The incidence of fungal infections caused by Aspergillus was higher (p < 0.05) in patients with hematologic malignancies than in the control group. The independent risk factors for fungal infections were fungal colonization, number of antibiotics and duration of antibiotic therapy, duration of fever and skin rash. A higher proportion of fungal infections was diagnosed on autopsy than during the patients' life (p < 0.01).
引用
收藏
页码:768 / 774
页数:7
相关论文
共 31 条
[1]   FUNGAL-INFECTIONS IN CANCER-PATIENTS - AN INTERNATIONAL AUTOPSY SURVEY [J].
BODEY, G ;
BUELTMANN, B ;
DUGUID, W ;
GIBBS, D ;
HANAK, H ;
HOTCHI, M ;
MALL, G ;
MARTINO, P ;
MEUNIER, F ;
MILLIKEN, S ;
NAOE, S ;
OKUDAIRA, M ;
SCEVOLA, D ;
VANTWOUT, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (02) :99-109
[2]   GENOTYPIC VARIATION AND SLIME PRODUCTION AMONG BLOOD AND CATHETER ISOLATES OF CANDIDA-PARAPSILOSIS [J].
BRANCHINI, ML ;
PFALLER, MA ;
RHINECHALBERG, J ;
FREMPONG, T ;
ISENBERG, HD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (02) :452-456
[3]  
DEBOCK R, 1994, BONE MARROW TRANSPL, V14, P1
[4]  
DEVITA VT, 1989, CANCER PRINCIPLES PR, P1775
[5]   CANDIDEMIA IN A TERTIARY CARE HOSPITAL - EPIDEMIOLOGY, RISK-FACTORS, AND PREDICTORS OF MORTALITY [J].
FRASER, VJ ;
JONES, M ;
DUNKEL, J ;
STORFER, S ;
MEDOFF, G ;
DUNAGAN, WC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (03) :414-421
[6]   LABORATORY DETECTION OF FUNGEMIA [J].
GEHA, DJ ;
ROBERTS, GD .
CLINICS IN LABORATORY MEDICINE, 1994, 14 (01) :83-97
[7]  
GOLDMAN M, 1993, MEDICINE, V72, P143, DOI 10.1097/00005792-199372030-00002
[8]   ENVIRONMENTAL SAMPLING FOR ASPERGILLI DURING BUILDING CONSTRUCTION ON A HOSPITAL SITE [J].
GOODLEY, JM ;
CLAYTON, YM ;
HAY, RJ .
JOURNAL OF HOSPITAL INFECTION, 1994, 26 (01) :27-35
[9]   EFFECT OF ABROGATION OF NATURAL-KILLER-CELL ACTIVITY ON THE COURSE OF CANDIDIASIS INDUCED BY INTRAPERITONEAL ADMINISTRATION AND GASTROINTESTINAL CANDIDIASIS IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY [J].
GREENFIELD, RA ;
ABRAMS, VL ;
CRAWFORD, DL ;
KUHLS, TL .
INFECTION AND IMMUNITY, 1993, 61 (06) :2520-2525
[10]   RISK-FACTORS FOR FUNGAL INFECTION IN PATIENTS WITH MALIGNANT HEMATOLOGIC DISORDERS - IMPLICATIONS FOR EMPIRICAL THERAPY AND PROPHYLAXIS [J].
GUIOT, HFL ;
FIBBE, WE ;
VANTWOUT, JW .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (04) :525-532